| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
39 Underperform | C$11.03M | 20.14 | 16.97% | ― | ― | ― | |
35 Underperform | C$2.41M | ― | ― | ― | ― | ― | |
34 Underperform | $3.97M | -14.47 | -13.76% | ― | ― | 82.88% | |
33 Underperform | C$6.26M | -6.93 | -17.86% | ― | ― | 92.11% | |
32 Underperform | C$10.74M | 7.55 | 12.49% | ― | ― | ― | |
20 Underperform | $5.33M | ― | ― | ― | ― | 24.42% |